Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Juliana Cano-Mejia

Showing results (1-10 of 8) with videos related to

Pageof 1
Sort By:
Small (Weinheim an Der Bergstrasse, Germany)|April 18, 2018
Photothermal Therapy Generates a Thermal Window of Immunogenic Cell Death in NeuroblastomaElizabeth E Sweeney, Juliana Cano-Mejia, Rohan Fernandes
Journal of Visualized Experiments : Jove|May 21, 2015
Biofunctionalized prussian blue nanoparticles for multimodal molecular imaging applicationsJennifer M Vojtech, Juliana Cano-Mejia, Matthieu F Dumont, et al.
Biomaterials Science|February 22, 2019
Prussian blue nanoparticle-based antigenicity and adjuvanticity trigger robust antitumor immune responses against neuroblastomaJuliana Cano-Mejia, Michelle L Bookstaver, Elizabeth E Sweeney, et al.
Translational Oncology|July 12, 2020
CpG-coated prussian blue nanoparticles-based photothermal therapy combined with anti-CTLA-4 immune checkpoint blockade triggers a robust abscopal effect against neuroblastomaJuliana Cano-Mejia, Anshi Shukla, Debbie K Ledezma, et al.
Advanced Nanobiomed Research|August 26, 2021
An Engineered Prussian Blue Nanoparticles-based Nanoimmunotherapy Elicits Robust and Persistent Immunological Memory in a TH-MYCN Neuroblastoma ModelAnshi Shukla, Juliana Cano-Mejia, Jaclyn Andricovich, et al.
Nanomaterials (Basel, Switzerland)|January 23, 2020
Indocyanine Green-Nexturastat A-PLGA Nanoparticles Combine Photothermal and Epigenetic Therapy for MelanomaDebbie K Ledezma, Preethi B Balakrishnan, Juliana Cano-Mejia, et al.
Nanomedicine : Nanotechnology, Biology, and Medicine|November 10, 2016
Prussian blue nanoparticle-based photothermal therapy combined with checkpoint inhibition for photothermal immunotherapy of neuroblastomaJuliana Cano-Mejia, Rachel A Burga, Elizabeth E Sweeney, et al.
Nano Research|September 12, 2022
CD137 agonist potentiates the abscopal efficacy of nanoparticle-based photothermal therapy for melanomaPreethi Bala Balakrishnan, Debbie K Ledezma, Juliana Cano-Mejia, et al.
Pageof 1

Showing results (1-10 of 8) with videos related to

Sort By:
Pageof 1
Small (Weinheim an Der Bergstrasse, Germany)|April 18, 2018
Photothermal Therapy Generates a Thermal Window of Immunogenic Cell Death in NeuroblastomaElizabeth E Sweeney, Juliana Cano-Mejia, Rohan Fernandes
Journal of Visualized Experiments : Jove|May 21, 2015
Biofunctionalized prussian blue nanoparticles for multimodal molecular imaging applicationsJennifer M Vojtech, Juliana Cano-Mejia, Matthieu F Dumont, et al.
Biomaterials Science|February 22, 2019
Prussian blue nanoparticle-based antigenicity and adjuvanticity trigger robust antitumor immune responses against neuroblastomaJuliana Cano-Mejia, Michelle L Bookstaver, Elizabeth E Sweeney, et al.
Translational Oncology|July 12, 2020
CpG-coated prussian blue nanoparticles-based photothermal therapy combined with anti-CTLA-4 immune checkpoint blockade triggers a robust abscopal effect against neuroblastomaJuliana Cano-Mejia, Anshi Shukla, Debbie K Ledezma, et al.
Advanced Nanobiomed Research|August 26, 2021
An Engineered Prussian Blue Nanoparticles-based Nanoimmunotherapy Elicits Robust and Persistent Immunological Memory in a TH-MYCN Neuroblastoma ModelAnshi Shukla, Juliana Cano-Mejia, Jaclyn Andricovich, et al.
Nanomaterials (Basel, Switzerland)|January 23, 2020
Indocyanine Green-Nexturastat A-PLGA Nanoparticles Combine Photothermal and Epigenetic Therapy for MelanomaDebbie K Ledezma, Preethi B Balakrishnan, Juliana Cano-Mejia, et al.
Nanomedicine : Nanotechnology, Biology, and Medicine|November 10, 2016
Prussian blue nanoparticle-based photothermal therapy combined with checkpoint inhibition for photothermal immunotherapy of neuroblastomaJuliana Cano-Mejia, Rachel A Burga, Elizabeth E Sweeney, et al.
Nano Research|September 12, 2022
CD137 agonist potentiates the abscopal efficacy of nanoparticle-based photothermal therapy for melanomaPreethi Bala Balakrishnan, Debbie K Ledezma, Juliana Cano-Mejia, et al.
Pageof 1